Virology drug development now includes therapies targeting viral replication, entry, proteases, polymerases, host pathways and immune responses. Companies are also […]
Viral vector manufacturing is one of the biggest production challenges in cell and gene therapy. Companies are under pressure to
Prescription affordability remains one of the biggest barriers to treatment access in the United States. Eli Lilly and Company offers
Oncology healthtech has become one of the most active areas of healthcare venture capital since 2020. Investment is flowing into
GLP-1-based medicines have become one of the most commercially important areas in pharmaceutical development, with companies competing on weight-loss efficacy,
Psoriasis and psoriatic arthritis (PsA) are chronic immune-mediated diseases that can create substantial long-term healthcare burden. For policymakers, the strongest
Takeda’s narcolepsy strategy goes beyond drug development. The company is working with academic sleep researchers, clinical centers, medical experts and
Not every CDMO that can manufacture sterile injectables is equipped to handle complex sterile formulations. Standard injectables may involve relatively
Theranostics combines molecular imaging with targeted treatment, allowing clinicians to identify suitable patients and then treat the same biological target.
The U.S. EHR landscape is highly concentrated. Epic, Oracle Health and MEDITECH remain the biggest hospital-focused vendors, while TruBridge, Altera